Text Size
70 studies found for:    "Anaplastic oligoastrocytoma"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: Surgery for placement;   Procedure: Radiation therapy;   Drug: Temozolomide with radiation therapy
22 Recruiting Cellular Immunotherapy Study for Brain Cancer
Conditions: Gliomas;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Glioma;   Glioblastoma Multiforme;   Malignant Meningioma
Intervention: Drug: alloreactive CTL
23 Recruiting Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Conditions: Low-grade Glioma;   Astrocytoma;   Oligodendroglioma;   Mixed Oligoastrocytoma
Intervention: Drug: RAD001
24 Recruiting A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma;   Malignant Astrocytoma NOS
Intervention: Drug: Nanoliposomal CPT-11
25 Active, not recruiting Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Conditions: Recurrent Anaplastic Astrocytoma;   Recurrent Anaplastic Oligodendroglioma;   Recurrent Anaplastic Oligo-Astrocytoma;   Recurrent Glioblastoma Multiforme
Intervention: Drug: Topotecan
26 Recruiting Combination Chemotherapy With BBBD Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: Etoposide phosphate;   Drug: Melphalan;   Drug: Carboplatin;   Drug: Sodium thiosulfate;   Drug: Filgrastim;   Drug: Pegfilgrastim
27 Unknown † Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
28 Completed Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Conditions: Anaplastic Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Interventions: Drug: Temozolomide;   Radiation: Focal radiotherapy
29 Active, not recruiting FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Conditions: Astrocytoma;   Oligoastrocytoma;   Oligodendroglioma
Intervention:
30 Recruiting Proton Radiation Therapy for Low Grade Gliomas
Conditions: Low Grade Gliomas;   Protoplasmic Astrocytomas;   Fibrillary Astrocytomas;   Gemistocytic Astrocytomas;   Oligoastrocytomas;   Oligodendrogliomas;   Other WHO Grade II/IV Gliomas
Intervention: Radiation: Proton radiation
31 Active, not recruiting HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
Conditions: Astrocytoma;   Oligoastrocytoma;   Oligodendroglioma
Intervention: Biological: Peptide vaccine + Poly-ICLC
32 Unknown † Treatment Strategy for Low-Grade Gliomas
Conditions: Astrocytomas;   Oligodendrogliomas;   Oligoastrocytoma
Interventions: Radiation: Radiation therapy;   Drug: Temozolomide
33 Terminated (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
Conditions: Low Grade Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Oligoastrocytoma
Intervention:
34 Unknown † 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   GBM;   Anaplastic Astrocytoma;   Oligo-Astrocytoma;   Gliosarcoma
Interventions: Drug: 131-I-TM-601;   Drug: 131I-TM601
35 Completed Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma;   Malignant Astrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
36 Completed Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
37 Completed Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
38 Recruiting Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
Conditions: Adult Diffuse Astrocytoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Recurrent Adult Brain Tumor;   Adult Oligoastrocytoma
Interventions: Biological: tumor lysate-pulsed autologous dendritic cell vaccine;   Other: laboratory biomarker analysis
39 Completed Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
40 Terminated Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma
Intervention: Drug: Talampanel
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years